Phrenic nerve stimulation
US-2024173074-A1 · May 30, 2024 · US
US10384050B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10384050-B2 |
| Application number | US-201515316482-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 24, 2015 |
| Priority date | Jun 25, 2014 |
| Publication date | Aug 20, 2019 |
| Grant date | Aug 20, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An implantable medical leads has a conductor that includes one or more metal wires and one or more carbon nanotube wires extending in substantially the same direction as the one or more metal wires. Such conductors may result in less MRI-induced heating at electrodes of leads than conductors that do not contain carbon nanotubes.
Opening claim text (preview).
The invention claimed is: 1. An implantable medical lead, comprising: a proximal end portion having a contact; a distal end portion having an electrode; a conductor electrically coupling the electrode to the contact; and a carbon nanotube structure coupled to the electrode and the conductor, but not the contact, wherein the carbon nanotube structure extends proximally in the lead from the electrode a distance sufficient to prevent heating of the electrode by more than 5° C. when the lead subjected to 1.5 T magnetic resonance imaging scanning at normal operating mode, and wherein heating at the electrode is tested by an in-vitro measure that is predictive of in-vivo electrode heating. 2. The implantable medical lead of claim 1 , wherein the carbon nanotube structure extends proximally in the lead from the electrode to a location more distal than the contact. 3. The implantable medical lead of claim 1 , wherein at least a portion of the conductor forms the electrode. 4. The implantable medical lead of claim 1 , wherein the conductor comprises one or more metal wires, and wherein the carbon nanotube structure comprises one or more carbon nanotube wires extending in a direction substantially the same as the one or more metal wires. 5. The implantable medical lead of claim 4 , wherein the one or more metal wires and the one or more carbon nanotube wires are twisted or braided around one another. 6. The implantable medical lead of claim 4 , wherein the one or more metal wire is formed from Cu, Au, Pt, Ag, MP35N, Ta, Nb, Ti, Mo, W, Pt—Ir, Pd, or a combination thereof. 7. An implantable medical lead, comprising: a proximal end portion having a contact; a distal end portion having an electrode; a conductor electrically coupling the electrode to the contact; and a carbon nanotube structure coupled to the electrode and the conductor, but not the contact, wherein the carbon nanotube structure extends proximally in the lead from the electrode a distance sufficient to reduce heating of the electrode by 50% or more relative to a substantially similar electrode that does not contain the carbon nanotube structure when the lead subjected to 1.5 T magnetic resonance imaging scanning or an equivalent thereof. 8. The implantable medical lead of claim 7 , wherein the conductor comprises one or more metal wires, and wherein the carbon nanotube structure comprises one or more carbon nanotube wires extending in a direction substantially the same as the one or more metal wires. 9. The implantable medical lead of claim 8 , wherein the one or more metal wires and the one or more carbon nanotube wires are twisted or braided around one another. 10. The implantable medical lead of claim 8 , wherein the one or more metal wire is formed from Cu, Au, Pt, Ag, MP35N, Ta, Nb, Ti, Mo, W, Pt—Ir, Pd, or a combination thereof.
Provisions within MR facilities for enhancing safety during MR, e.g. reduction of the specific absorption rate [SAR], detection of ferromagnetic objects in the scanner room · CPC title
Invasive instruments, e.g. catheters or biopsy needles, specially adapted for tracking, guiding or visualization by NMR · CPC title
Monitoring of or protection against external electromagnetic fields or currents · CPC title
Magnetic resonance imaging [MRI] compatible leads · CPC title
for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.